Q2 2015 13F Holders as of 30 Jun 2015
-
Type / Class
-
Equity / NY ARCA BIOTECH
-
Number of holders
-
122
-
Total 13F shares, excl. options
-
18.5M
-
Shares change
-
+2.28M
-
Total reported value, excl. options
-
$2.29B
-
Value change
-
+$283M
-
Put/Call ratio
-
0.48
-
Number of buys
-
62
-
Number of sells
-
-46
-
Price
-
$124.02
Significant Holders of FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) as of Q2 2015
134 filings reported holding FBT - FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH as of Q2 2015.
FIRST TR EXCHANGE-TRADED FD - NY ARCA BIOTECH (FBT) has 122 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 18.5M shares
.
Largest 10 shareholders include FIRST TRUST ADVISORS LP (8.08M shares), MORGAN STANLEY (2.66M shares), WELLS FARGO & COMPANY/MN (2.05M shares), UBS Group AG (951K shares), BANK OF AMERICA CORP /DE/ (827K shares), RAYMOND JAMES & ASSOCIATES (474K shares), LPL Financial LLC (344K shares), GOLDMAN SACHS GROUP INC (300K shares), ROYAL BANK OF CANADA (227K shares), and Transamerica Financial Advisors, Inc. (137K shares).
This table shows the top 122 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.